Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001439222-23-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | 2023-02-16 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | S - Sale | $27.21 | -233 | 2,668 | -8% | -$6,340 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-02-16 | S | D | 233 | $27.21 | 2,668 | D | — | — |